Literature DB >> 35787179

Role of CB1 receptors in the acute regulation of small intestinal permeability: effects of high-fat diet.

Hailey Cuddihey1,2,3, Jean-Baptiste Cavin1,2,4,3, Catherine M Keenan1,2,3, Laurie E Wallace1,2,3, Kiran Vemuri5,6, Alexandros Makriyannis5,6, Wallace K MacNaughton2,4,3, Keith A Sharkey1,2,3.   

Abstract

The endocannabinoid system of the gastrointestinal tract is involved in the control of intestinal barrier function. Whether the cannabinoid 1 (CB1) receptor is expressed on the intestinal epithelium and acutely regulates barrier function has not been determined. Here, we tested the hypothesis that ligands of the CB1 receptor acutely modulate small intestinal permeability and that this is associated with altered distribution of tight junction proteins. We examined the acute effects of CB1 receptor ligands on small intestinal permeability both in chow-fed and 2-wk high-fat diet (HFD)-fed mice using Ussing chambers. We assessed the distribution of CB1 receptor and tight junction proteins using immunofluorescence and the expression of CB1 receptor using PCR. A low level of CB1 expression was found on the intestinal epithelium. CB1 receptor was highly expressed on enteric nerves in the lamina propria. Neither the CB1/CB2 agonist CP55,940 nor the CB1 neutral antagonist AM6545 altered the flux of 4kDa FITC dextran (FD4) across the jejunum or ileum of chow-fed mice. Remarkably, both CP55,940 and AM6545 reduced FD4 flux across the jejunum and ileum in HFD-fed mice that have elevated baseline intestinal permeability. These effects were absent in CB1 knockout mice. CP55,940 reduced the expression of claudin-2, whereas AM6545 had little effect on claudin-2 expression. Neither ligand altered the expression of ZO-1. Our data suggest that CB1 receptor on the intestinal epithelium regulates tight junction protein expression and restores barrier function when it is increased following exposure to a HFD for 2 wk.NEW & NOTEWORTHY The endocannabinoid system of the gastrointestinal tract regulates homeostasis by acting as brake on motility and secretion. Here we show that when exposed to a high fat diet, intestinal permeability is increased and activation of the CB1 receptor on the intestinal epithelium restores barrier function. This work further highlights the role of the endocannabinoid system in regulating intestinal homeostasis when it is perturbed.

Entities:  

Keywords:  Ussing chambers; claudin-2; endocannabinoid system; enteric nervous system; zonula occludens-1

Mesh:

Substances:

Year:  2022        PMID: 35787179      PMCID: PMC9394780          DOI: 10.1152/ajpgi.00341.2021

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.871


  84 in total

1.  Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.

Authors:  S Houle; J F Larrivée; M Bachvarova; J Bouthillier; D R Bachvarov; F Marceau
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

2.  Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.

Authors:  K Tyler; C J Hillard; B Greenwood-Van Meerveld
Journal:  Eur J Pharmacol       Date:  2000-12-08       Impact factor: 4.432

3.  Good fences make good neighbors: Gastrointestinal mucosal structure.

Authors:  Hannah L Turner; Jerrold R Turner
Journal:  Gut Microbes       Date:  2010-01

4.  Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.

Authors:  Fengjun Wang; W Vallen Graham; Yingmin Wang; Edwina D Witkowski; Brad T Schwarz; Jerrold R Turner
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease.

Authors:  R M van Elburg; J J Uil; C J Mulder; H S Heymans
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

6.  Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.

Authors:  Christopher R Weber; Sam C Nalle; Maria Tretiakova; David T Rubin; Jerrold R Turner
Journal:  Lab Invest       Date:  2008-08-18       Impact factor: 5.662

7.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 8.  Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.

Authors:  Patrice D Cani; Hubert Plovier; Matthias Van Hul; Lucie Geurts; Nathalie M Delzenne; Céline Druart; Amandine Everard
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

9.  Polyunsaturated fatty acids reduce fatty acid synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression and promote apoptosis in HepG2 cell line.

Authors:  Maria Notarnicola; Caterina Messa; Maria G Refolo; Valeria Tutino; Angelica Miccolis; Maria G Caruso
Journal:  Lipids Health Dis       Date:  2011-01-18       Impact factor: 3.876

10.  Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex.

Authors:  Rebeca Diez-Alarcia; Inés Ibarra-Lecue; Ángela P Lopez-Cardona; Javier Meana; Alfonso Gutierrez-Adán; Luis F Callado; Ekaitz Agirregoitia; Leyre Urigüen
Journal:  Front Pharmacol       Date:  2016-11-04       Impact factor: 5.810

View more
  2 in total

Review 1.  Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis.

Authors:  Hailey Cuddihey; Wallace K MacNaughton; Keith A Sharkey
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-06-22

2.  Diet-Induced Gut Barrier Dysfunction Is Exacerbated in Mice Lacking Cannabinoid 1 Receptors in the Intestinal Epithelium.

Authors:  Mark B Wiley; Nicholas V DiPatrizio
Journal:  Int J Mol Sci       Date:  2022-09-11       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.